Medical News

RSS

AstraZeneca signs definitive agreement to acquire Novexel

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial drug resistance, announces today that its shareholders have signed a definitive agreement whereby Novexel shall be acquired by AstraZeneca for a total cash consideration of up to $505 million, including contingent payments and the net cash position of the company at closing.

24 Dec 2009

Pyng Medical releases audited fiscal 2009 results for September 30, 2009

Pyng Medical Corp. today released its audited fiscal 2009 results for the year ended September 30, 2009. Pyng reported fourth quarter sales were $1,718,272 and total annual sales of $6,026,177. Net loss before tax for the year was $62,904 and after tax was $246,904.

24 Dec 2009

Planet Green to be acquired by IMAGIN Molecular

IMAGIN Molecular Corporation (OTCBB: IMGM) has agreed in a letter of intent to issue 49% of the post capitalization of IMGM in exchange for 84,000,000 Positron Corporation common shares plus 100% of the equity of the Planet Green Bottle, all IMGM shares to be distributed to shareholders or affiliates of Planet Green.

24 Dec 2009

Opinions: Doctors in developing nations; foreign aid

In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.

24 Dec 2009

MiMedx Group launches its Paradis Vaso Shield vessel cover product

MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.

24 Dec 2009

Lawmakers, public take aim at deal struck for Sen. Nelson

News outlets report on deals struck with individual senators, in particular Sen. Ben Nelson, D-Neb., in an effort to win support for health care legislation.

24 Dec 2009

New energy receptor theory of brain function

Dr. Mitchell Earl Gibson, best-selling author, board-certified physician, and CEO of Tybro Publications, has proposed a new energy receptor theory of brain function that might explain the efficacy of mantras and prayer in human illness.

24 Dec 2009

Intervention strategy brings positive changes in type 2 diabetic patients

South Dakota State University research showed an intervention strategy based on the Native American spiritual concept of the Medicine Wheel brought positive changes for diabetics.

24 Dec 2009

VOA News examines obstetric fistula in Africa

VOA News examines obstetric fistula in Africa and looks at health officials' efforts to prevent and treat the condition.

24 Dec 2009

IRIN series examines health, development issues in Kenya

In a special series, IRIN examines health and development in Kenya. "The vast arid lands of northern Kenya are generally drier, less fertile, poorer and rank lower in most humanitarian and development league tables than the rest of the country. ... Preventable and treatable diseases are often neither prevented nor treated for want of adequate healthcare. Attracting qualified doctors and nurses to the hinterland is a major challenge.

24 Dec 2009

Merck discontinues MK-1903 niacin receptor agonist development program with Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. announced today Merck and Co., Inc.'s decision (through an affiliate) to discontinue development of MK-1903, an investigational niacin receptor agonist to treat atherosclerosis being developed under its research collaboration with Arena. Merck also informed Arena that the company will not continue the collaboration.

24 Dec 2009

AARP calls on Senators to vote in favor of health care reform bill

While Washington, D.C. couldn't seem further away to most Idaho families this holiday season, rising health care costs are an issue that's hitting much closer to home. As Idaho's health care woes grow increasingly worse, AARP is calling on Senators Mike Crapo and Jim Risch to vote in favor of the Senate health care reform bill expected to come up for a vote Christmas Eve, and is sending the Senators a "Christmas List" of Idaho's health care crisis.

24 Dec 2009

HHS announces additional grant programs to support health IT workforce

The Office of the National Coordinator for Health Information Technology (ONC) in the Department of Health and Human Services (HHS) announced today the availability of two additional grant programs to support the training and development of the skilled workforce required to support broad adoption and use of health information technology (health IT).

24 Dec 2009

Republicans bitter about deals, resigned about likely overhaul passage

After a series of last minute deals paved the way for Senate Democrats to move forward with health overhaul legislation, Republicans lashed out, but also acknowledged that their options for fighting the legislation at this late date are limited.

24 Dec 2009

LA hospital illustrates dilemma of expensive end of life care

End-of-life care has become a target for critics who allege many hospitals and physicians order unnecessary and expensive procedures, but it often involves difficult and complex decision-making. The New York Times reports on one hospital with large end-of-life care bills:

24 Dec 2009

Bovie Medical's Resistick II coated electrodes receive FDA 510(k) clearance

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company has received 510(k) clearance from the Food and Drug Administration (FDA) to market its line of coated blades, needles and ball electrodes used for cutting and coagulating soft tissues during surgical procedures. Resistick II is coating applied to stainless steel which resists eschar (scab or scar tissue caused by burning) during surgery. The coated electrodes continue the expansion of the Bovie line of electrosurgical disposables.

23 Dec 2009

Elusys Therapeutics receives contract to speed up drug development for Anthrax

The HHS Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to Elusys Therapeutics, Inc. of Pine Brook, N.J., for the advanced development of a medication to treat inhalational anthrax, one of the top bioterrorism threats facing the nation.

23 Dec 2009

Ligand Pharmaceuticals acquires Neurogen

Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation, following approval of the transaction by Neurogen stockholders earlier today. As a result, Ligand gains a fully funded partnership with Merck & Co., additional pipeline assets, drug discovery resources and additional cash balances.

23 Dec 2009

Lawmakers brace for conference as House Liberals vow not to give in on key issues

The Los Angeles Times reports that Democrats are looking ahead — and at each other — before beginning the "potentially difficult" process of reconciling the Senate and House versions of health care reform.

23 Dec 2009

Nursing shortage awaits baby boomers

CNNMoney reports: "Baby boomers are getting older and will require more care than ever, taxing an already strained nursing system. America has had a nursing shortage for years, said Peter Buerhaus, workforce analyst at Vanderbilt University School of Nursing in Nashville, Tenn. But by 2025, the country will be facing a shortfall of 260,000 RNs, he said."

23 Dec 2009